ATE123294T1 - Antiherpes-tetrapeptid-derivate mit einer substituierten seitenkette aus asparaginsäure. - Google Patents

Antiherpes-tetrapeptid-derivate mit einer substituierten seitenkette aus asparaginsäure.

Info

Publication number
ATE123294T1
ATE123294T1 AT90112645T AT90112645T ATE123294T1 AT E123294 T1 ATE123294 T1 AT E123294T1 AT 90112645 T AT90112645 T AT 90112645T AT 90112645 T AT90112645 T AT 90112645T AT E123294 T1 ATE123294 T1 AT E123294T1
Authority
AT
Austria
Prior art keywords
antiherpes
substituted
side chain
acid side
hydrogen
Prior art date
Application number
AT90112645T
Other languages
English (en)
Inventor
Julian Adams
Pierre Louis Beaulieu
Robert Deziel
Neil Moss
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA000605061A external-priority patent/CA1340681C/en
Priority claimed from CA 2019006 external-priority patent/CA2019006C/en
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Application granted granted Critical
Publication of ATE123294T1 publication Critical patent/ATE123294T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
AT90112645T 1989-07-07 1990-07-03 Antiherpes-tetrapeptid-derivate mit einer substituierten seitenkette aus asparaginsäure. ATE123294T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA000605061A CA1340681C (en) 1989-07-07 1989-07-07 Antiherpes tetrapeptides having a substituted aspartic acid side chain
CA 2019006 CA2019006C (en) 1990-06-14 1990-06-14 Antiherpes tetrapeptide derivatives having a cycloalkyl substituted aspartic acid side chain

Publications (1)

Publication Number Publication Date
ATE123294T1 true ATE123294T1 (de) 1995-06-15

Family

ID=25672868

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90112645T ATE123294T1 (de) 1989-07-07 1990-07-03 Antiherpes-tetrapeptid-derivate mit einer substituierten seitenkette aus asparaginsäure.

Country Status (6)

Country Link
EP (1) EP0411333B1 (de)
JP (1) JP2879799B2 (de)
AT (1) ATE123294T1 (de)
AU (1) AU643403B2 (de)
DE (1) DE69019786T2 (de)
IL (1) IL94982A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340682C (en) * 1989-07-07 1999-07-27 Pierre Lavallee Antiviral peptides having a 2-oxoalkyl amino acid side chain
AU643636B2 (en) * 1989-07-07 1993-11-18 Bio-Mega/Boehringer Ingelheim Research Inc. Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain
EP0560267B1 (de) * 1992-03-12 1998-08-19 Boehringer Ingelheim (Canada) Ltd. Isosterische Peptidderivate gegen Herpes
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
EP0292255A3 (de) * 1987-05-22 1990-08-22 Merck & Co. Inc. Hemmungsstoff für Ribonukleotid-Reduktase
CA1327869C (en) * 1989-02-17 1994-03-15 Yvan Guindon Ribonucleotide reductase inhibitors
CA1340682C (en) * 1989-07-07 1999-07-27 Pierre Lavallee Antiviral peptides having a 2-oxoalkyl amino acid side chain
AU643636B2 (en) * 1989-07-07 1993-11-18 Bio-Mega/Boehringer Ingelheim Research Inc. Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain

Also Published As

Publication number Publication date
EP0411333A1 (de) 1991-02-06
JPH03215495A (ja) 1991-09-20
EP0411333B1 (de) 1995-05-31
DE69019786D1 (de) 1995-07-06
JP2879799B2 (ja) 1999-04-05
DE69019786T2 (de) 1995-11-16
IL94982A (en) 1995-11-27
AU643403B2 (en) 1993-11-11
AU5877690A (en) 1991-01-10
IL94982A0 (en) 1991-06-10

Similar Documents

Publication Publication Date Title
EP0906907A4 (de)
CA2136622A1 (fr) Composes biologiquement actifs de type phosphotriesters
CA2027206A1 (en) Sulphonylaminocarbonyltriazolinones
ATE120202T1 (de) Antiherpes-peptidderivate mit einem 1,4-dioxo-c4- n-terminus.
ATE123294T1 (de) Antiherpes-tetrapeptid-derivate mit einer substituierten seitenkette aus asparaginsäure.
AU643448B2 (en) Antiviral peptides having a 2-Oxoalkyl amino acid side chain
ATE118785T1 (de) Pentapeptidderivate, wirksam gegen herpes, die eine ersetzte asparaginsäureseitenkette enthalten.
FI944187A (fi) Isosteeriset antiherpespeptidijohdannaiset
AU623500B2 (en) Carboxylimino benzothiazole derivatives
DE69028953D1 (de) Antiherpes-Pentapeptide
CA2019006A1 (en) Antiherpes tetrapeptide derivatives having a cycloalkyl substituted aspartic acid side chain
GR3021045T3 (en) 1-Alkyl-2-acyl-1,2-disulfonylhydrazines with antineoplastic activity
CA2019005A1 (en) Antiherpes pentapeptide derivatives having a cycloalkyl substituted aspartic acid side chain

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties